How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,842 results for

Pelvic Inflammatory Disease

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pelvic inflammatory disease

Pelvic inflammatory disease Evidence Maps - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) of known issues . Also read , explaining issues with the system. NOTE : Chrome is the best browser to use! To get started, type a condition/disease into the search box above. Here are some examples to get you started: Building Evidence Map X Axis Alphabetically Risk of bias No. Articles Sample Size Risk of bias any low Minimum sample size Apply Follow us: © 2019 Trip Database Ltd. company number 04316414. Trip is proud to be made in the UK.

2018 Trip Evidence Maps

3. Pelvic inflammatory disease

Pelvic inflammatory disease Pelvic inflammatory disease - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Pelvic inflammatory disease Last reviewed: February 2019 Last updated: February 2018 Summary Pelvic inflammatory disease is an acute ascending polymicrobial infection of the female gynaecological tract that is frequently associated with Neisseria gonorrhoeae or Chlamydia trachomatis . Symptoms and physical findings (...) due to scarred or obstructed fallopian tubes. Definition Pelvic inflammatory disease (PID) comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis. Sexually transmitted organisms, especially Neisseria gonorrhoeae and Chlamydia trachomatis , are implicated in many cases; however, micro-organisms that comprise the vaginal flora (e.g., anaerobes, Gardnerella vaginalis

2018 BMJ Best Practice

4. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update)

United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update) United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update) Guideline development group: Jonathan Ross (lead author), Michelle Cole, Ceri Evans, Deirdre Lyons, Gillian Dean, Darren Cousins, PPI representative What is new in the 2019 interim update? • the European Medicines Agency has released new guidance highlighting the potential for disabling (...) principles needed for the effective management of pelvic inflammatory disease (PID) covering the management of the initial presentation, as well as how to reduce transmission, complications and future repeat infection. It is aimed primarily at women aged 16 years or older (see specific guidelines for those under 16) presenting to health care professionals working in departments offering specialist care in STI management within the United Kingdom. However, the principles of the recommendations should

2019 British Association for Sexual Health and HIV

5. Antibiotic therapy for pelvic inflammatory disease. (PubMed)

Antibiotic therapy for pelvic inflammatory disease. Pelvic inflammatory disease (PID) is an infection that affects 4% to 12% of young women, and is one of the most common causes of morbidity in this age group. The main intervention for acute PID is the use of broad-spectrum antibiotics which cover Chlamydia trachomatis, Neisseria gonorrhoeae, and anaerobic bacteria, administered intravenously, intramuscularly, or orally. In this review, we assessed the optimal treatment regimen for PID.To (...) assess the effectiveness and safety of antibiotic regimens used to treat pelvic inflammatory disease.We searched the Cochrane Sexually Transmitted Infections Review Group's Specialized Register, which included randomized controlled trials (RCTs) from 1944 to 2016, located through electronic searching and handsearching; the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid platform (1991 to July 2016); MEDLINE (1946 to July 2016); Embase (1947 to July 2016); LILACS, iAHx interface (1982

Full Text available with Trip Pro

2017 Cochrane

6. Pelvic Inflammatory Disease (PID)

Pelvic Inflammatory Disease (PID) Pelvic Inflammatory Disease Management Guidelines page 1 of 4 The Ministry of Health supports the use of these clinical guidelines, developed by clinical experts and professional associations to guide clinical care. Further guideline information – www.nzshs.org/guidelines or phone a sexual health specialist. This STI Management Guideline Summary has been produced by NZSHS. Every effort has been taken to ensure that the information in this guideline is correct (...) at the time of publishing (September 2017). Pelvic Inflammatory Disease (PID) MANAGEMENT SUMMARY 72 HOUR FOLLOW-UP FOR MODERATE/SEVERE PID • Repeat bimanual exam to assess resolution of signs and refer if not improved • No unprotected sex? • Tolerated medication? • Notifiable contacts informed? • Any risk of reinfection? Will need further treatment if re-exposed to untreated contact 1 TO 2 WEEK FOLLOW-UP FOR MILD PID (PHONE OR IN PERSON) • As above – bimanual where practical or where symptoms not improved

2017 New Zealand Sexual Health Society

7. 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease

2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease 2 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease Guideline development group: Jonathan Ross (lead author), Michelle Cole, Ceri Evans, Deirdre Lyons, Gillian Dean, Darren Cousins, PPI representative What is new in the 2018 update? ? the role of Mycoplasma genitalium (...) suggested as empirical treatment for male partners of women with PID to reduce exposure to macrolide antibiotics which has been associated with increased resistance in M. genitalium ? references have been updated ? the Grade system for reporting strength of evidence has been adopted 3 Introduction and methodology Objectives This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of pelvic inflammatory disease

2018 British Association for Sexual Health and HIV

8. The Additive Value of Pelvic Examinations to History in Predicting Sexually Transmitted Infections for Young Female Patients With Suspected Cervicitis or Pelvic Inflammatory Disease

The Additive Value of Pelvic Examinations to History in Predicting Sexually Transmitted Infections for Young Female Patients With Suspected Cervicitis or Pelvic Inflammatory Disease We evaluate the additive value of pelvic examinations in predicting sexually transmitted infection for young female patients with suspected cervicitis or pelvic inflammatory disease in a pediatric emergency department (ED).This was a prospective observational study of female patients aged 14 to 20 years who (...) presented to an urban academic pediatric ED with a complaint of vaginal discharge or lower abdominal pain. Enrolled patients provided a urine sample for chlamydia, gonorrhea, and trichomonas testing, which served as the criterion standard for diagnosis. A practitioner (pediatric ED attending physician, emergency medicine or pediatric resident, pediatric ED fellow, or advanced practice provider) obtained a standardized history from the patient to assess for cervicitis or pelvic inflammatory disease

2018 EvidenceUpdates

9. Diagnostic accuracy of pelvic examination in pelvic inflammatory disease: a meta-analysis of CDC diagnostic minimal clinical criteria.

Diagnostic accuracy of pelvic examination in pelvic inflammatory disease: a meta-analysis of CDC diagnostic minimal clinical criteria. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration (...) of index ischemia (linear); stem cell dose (linear); blinding of outcome assessment reported (stratified yes vs no). For stratified analyses, a minimum number of 8 studies per subgroup is required. ">Subgroup analyses A sensitivity analysis is conducted to assess the impact of decisions taken in the review process on the meta-analysis outcome. These decisions may have been made in various stages of the review, e.g. the decision to exclude certain disease models, the decision to pool certain units

2019 PROSPERO

10. The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-<i>κ</i>B and BAX/BCL-2 Pathway. (PubMed)

The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway. Although gastroenteritis and pelvic inflammatory disease (PID) occur in the gastrointestinal tract and pelvis, respectively, they display similar pathogeneses. The incidence of inflammation in these conditions is usually associated with dysbacteriosis, and, at times, they are caused by the same pathogenic bacteria (...) , Escherichia coli and Streptococcus aureus. Feiyangchangweiyan capsule (FYC) is a traditional Chinese patent medicine that is widely used to treat bacterial dysentery and acute and chronic gastroenteritis. However, whether it has an effect on PID is unclear. The aim of this study was to investigate the anti-inflammatory effect of FYC and its main components, gallic acid (GA), ellagic acid (EA), and syringin (SY), on a pathogen-induced PID model and illustrate their potential mechanism of action. Female

2019 Evidence-based Complementary and Alternative Medicine (eCAM)

11. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. (PubMed)

Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. The aims of this work were: (i) to profile and compare pelvic and cervical microbiota from patients with pelvic inflammatory disease (PID); (ii) to test the ascending infection hypothesis that the microbes in the vagina or cervix spread to the upper genital tract and cause PID.Thirty-eight PID patients and 19 control patients were enrolled in this study and received salpingectomy or salpingo (...) -oophorectomy. Both pelvic and cervical samples were collected during surgery, which were subject to culture diagnosis and next-generation sequencing (NGS)-based 16S rRNA profiling.For the PID group, the NGS-based method revealed that half of the pelvic samples were dominated by a single organism while the other half exhibited a polymicrobial infection. The pelvic and cervical microbiota were similar in terms of both taxonomic richness and evenness. Pelvic microbiota was dominated by Acinetobacter

2018 Journal of Medical Microbiology

12. The Additive Value of Pelvic Examinations to History in Predicting Sexually Transmitted Infections for Young Female Patients With Suspected Cervicitis or Pelvic Inflammatory Disease. (PubMed)

The Additive Value of Pelvic Examinations to History in Predicting Sexually Transmitted Infections for Young Female Patients With Suspected Cervicitis or Pelvic Inflammatory Disease. We evaluate the additive value of pelvic examinations in predicting sexually transmitted infection for young female patients with suspected cervicitis or pelvic inflammatory disease in a pediatric emergency department (ED).This was a prospective observational study of female patients aged 14 to 20 years who (...) presented to an urban academic pediatric ED with a complaint of vaginal discharge or lower abdominal pain. Enrolled patients provided a urine sample for chlamydia, gonorrhea, and trichomonas testing, which served as the criterion standard for diagnosis. A practitioner (pediatric ED attending physician, emergency medicine or pediatric resident, pediatric ED fellow, or advanced practice provider) obtained a standardized history from the patient to assess for cervicitis or pelvic inflammatory disease

2018 Annals of Emergency Medicine

13. Fuke Qianjin combined with antibiotics in treatment of acute pelvic inflammatory disease (PID): a systematic review

Fuke Qianjin combined with antibiotics in treatment of acute pelvic inflammatory disease (PID): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated (...) cell dose (linear); blinding of outcome assessment reported (stratified yes vs no). For stratified analyses, a minimum number of 8 studies per subgroup is required. ">Subgroup analyses A sensitivity analysis is conducted to assess the impact of decisions taken in the review process on the meta-analysis outcome. These decisions may have been made in various stages of the review, e.g. the decision to exclude certain disease models, the decision to pool certain units of measurement for an outcome

2019 PROSPERO

14. Anti-Inflammatory Effect of Feiyangchangweiyan Capsule on Rat Pelvic Inflammatory Disease through JNK/NF-<i>κ</i>B Pathway. (PubMed)

Anti-Inflammatory Effect of Feiyangchangweiyan Capsule on Rat Pelvic Inflammatory Disease through JNK/NF-κB Pathway. In this study, we aimed to illustrate the preventive effect and possible mechanisms of Feiyangchangweiyan capsule (FYCWYC) on rat pelvic inflammatory disease (PID) model.To construct the rat PID model, upper genital tract was infected by multipathogen, and then drugs were orally administered for 8 days. The histological examination, immunohistochemical analysis, and ELISA (...) only decreased the phosphorylation of JNK induced by infection and had no effects on Akt and P38. Additional, the effects of SP600125, an inhibitor of phospho-JNK, were similar to the results of FYCWYC.Taken together, our results demonstrated that FYCWYC had anti-inflammatory effect in pathogen-induced PID model, and the mechanism might be through inhibiting NF-κB nuclear translocation which is mediated by JNK.

Full Text available with Trip Pro

2018 Evidence-based Complementary and Alternative Medicine (eCAM)

15. Chlamydia trachomatis in women with pelvic inflammatory disease (PID): report from a tertiary center in eastern Nepal. (PubMed)

Chlamydia trachomatis in women with pelvic inflammatory disease (PID): report from a tertiary center in eastern Nepal. Chlamydia trachomatis is an important agent of pelvic inflammatory disease (PID) globally. Laboratory diagnosis, which is vital for early and appropriate treatment, remains a challenge in resource-limited settings. Our study was undertaken to detect C. trachomatis in women with clinical features of PID. Three endocervical swabs, each obtained from 100 women clinically diagnosed

2019 Tropical Doctor

16. Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. (PubMed)

Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. To compare operative outcomes of laparoscopic surgery compared with laparotomy in patients with moderate to severe pelvic inflammatory disease (PID).Using the Diagnosis Procedure Combination database, a national inpatient database for acute-care inpatients in Japan, we performed a large, nationwide retrospective cohort study. We identified all patients aged 18 years or older who were

2019 Obstetrics and Gynecology

17. Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. (PubMed)

Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. To compare operative outcomes of laparoscopic surgery compared with laparotomy in patients with moderate to severe pelvic inflammatory disease (PID).Using the Diagnosis Procedure Combination database, a national inpatient database for acute-care inpatients in Japan, we performed a large, nationwide retrospective cohort study. We identified all patients aged 18 years or older who were

2019 Obstetrics and Gynecology

18. A Matched Case-Control Analysis of Clinical Outcomes for Inflammatory Bowel Disease Patients with Rectal Cancer Treated with Pelvic Radiation Therapy. (PubMed)

A Matched Case-Control Analysis of Clinical Outcomes for Inflammatory Bowel Disease Patients with Rectal Cancer Treated with Pelvic Radiation Therapy. Inflammatory bowel disease (IBD) is a known risk factor for rectal cancer, and radiation therapy (RT) is often an important part of therapy for these patients. Previously published studies have raised concerns for increased rates of RT toxicity in IBD patients. We performed a matched case-control analysis to assess RT-related toxicity in a large

2019 Biology and Physics

19. Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients. (PubMed)

Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients. We evaluated the risk of pelvic inflammatory disease (PID), ectopic pregnancy, and infertility in women with a previous Chlamydia trachomatis (CT) diagnosis compared with women who tested negative for CT and CT untested women, considering both targeted and incidental (ie, prescribed for another indication) use of CT-effective (...) reproductive health outcomes. Moreover, this risk increased with repeat CT infections. CT-effective antibiotic use showed no decreased risks of subsequent PID regardless of CT history. Our results confirm the reproductive health burden of CT, which requires adequate public health interventions.© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

2019 Clinical Infectious Diseases

20. Anti-inflammatory Effects of the Natural Compounds Cortex Phellodendri and Humulus japonicus on Pelvic Inflammatory Disease in Mice (PubMed)

Anti-inflammatory Effects of the Natural Compounds Cortex Phellodendri and Humulus japonicus on Pelvic Inflammatory Disease in Mice Pelvic inflammatory disease (PID) is an inflammatory and/or infectious disorder of the upper female genital tract, including the uterus, fallopian tubes, and adjacent pelvic structures, that may spread upward to the peritoneum. Currently available treatment options have presented to produce adverse effects of various degrees, such as increased antimicrobial (...) resistance and a limited effective duration of hormones. In the study, the Cortex Phellodendri (CP) and Humulus japonicus (HJ) among natural compounds that are believed to present biological activities with fewer side effects were tested in a PID animal model. The results suggested that the administration CP and HJ reduced clinical signs, inflammatory cytokine expression as well as secretion in uterine tissue, and neutrophil infiltration into the tissue.

Full Text available with Trip Pro

2017 International journal of medical sciences

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>